484 related articles for article (PubMed ID: 10809194)
1. Hypofixation and hyperfixation of 99mTc-hexamethyl propyleneamine oxime in subacute cerebral infarction.
Ogasawara K; Ogawa A; Koshu K; Konno H; Suzuki M; Yoshimoto T
J Nucl Med; 2000 May; 41(5):795-9. PubMed ID: 10809194
[TBL] [Abstract][Full Text] [Related]
2. Dynamic and static 99mTc-ECD SPECT imaging of subacute cerebral infarction: comparison with 133Xe SPECT.
Ogasawara K; Ogawa A; Ezura M; Konno H; Doi M; Kuroda K; Yoshimoto T
J Nucl Med; 2001 Apr; 42(4):543-7. PubMed ID: 11337539
[TBL] [Abstract][Full Text] [Related]
3. [Quantification of regional cerebral blood flow using 99mTc-HMPAO SPECT and intravenous 133Xe injection method].
Isaka Y; Iiji O; Imaizumi M; Ashida K; Itoi Y
Kaku Igaku; 1992 Dec; 29(12):1463-73. PubMed ID: 1491492
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and metabolic state of hyperfixation with 99mTc-HMPAO brain SPECT in subacute stroke.
Cho I; Hayashida K; Imakita S; Kume N; Fukuchi K
Ann Nucl Med; 2000 Jun; 14(3):159-63. PubMed ID: 10921479
[TBL] [Abstract][Full Text] [Related]
5. Remote regional cerebral blood flow consequences of focused infarcts of the medulla, pons and cerebellum.
Rousseaux M; Steinling M
J Nucl Med; 1999 May; 40(5):721-9. PubMed ID: 10319742
[TBL] [Abstract][Full Text] [Related]
6. Discrepant 99mTc-ECD images of CBF in patients with subacute cerebral infarction: a comparison of CBF, CMRO2 and 99mTc-HMPAO imaging.
Shishido F; Uemura K; Inugami A; Ogawa T; Fujita H; Shimosegawa E; Nagata K
Ann Nucl Med; 1995 Aug; 9(3):161-6. PubMed ID: 8534592
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.
Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA
J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465
[TBL] [Abstract][Full Text] [Related]
8. Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT.
Payne JK; Trivedi MH; Devous MD
J Nucl Med; 1996 Oct; 37(10):1735-40. PubMed ID: 8862321
[TBL] [Abstract][Full Text] [Related]
9. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison.
Asenbaum S; Brücke T; Pirker W; Pietrzyk U; Podreka I
J Nucl Med; 1998 Apr; 39(4):613-8. PubMed ID: 9544665
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of (99m)Tc-HMPAO-SPECT for neurological Outcome/Recovery at the acute stage of stroke.
Marchal G; Bouvard G; Iglesias S; Sebastien B; Benali K; Defer G; Viader F; Baron JC
Cerebrovasc Dis; 2000; 10(1):8-17. PubMed ID: 10629341
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of rCBF by 99mTc-hexamethylpropyleneamine oxime single photon emission computed tomography combined with 133Xe CBF.
Isaka Y; Itoi Y; Imaizumi M; Ashida K; Okamoto M; Iiji O
J Cereb Blood Flow Metab; 1994 Mar; 14(2):353-7. PubMed ID: 8113331
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the clinical usefulness of super dynamic 99mTc-HM-PAO SPECT in ischemic cerebrovascular disease--detection of hypo- and hyperperfusion area].
Toyama H; Takeshita G; Shibata K; Nomura M; Fujiwara T; Ishikawa E; Fujiwara M; Fujii N; Ejiri K; Maeda H; Katada K; Takeuchi A; Koga S
Kaku Igaku; 1996 May; 33(5):521-9. PubMed ID: 8699620
[TBL] [Abstract][Full Text] [Related]
13. Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography.
Hayashida K; Fukuchi K; Inubushi M; Fukushima K; Imakita S; Kimura K
J Nucl Med; 2001 Jun; 42(6):859-63. PubMed ID: 11390548
[TBL] [Abstract][Full Text] [Related]
14. [A case of subacute stroke with high uptake of 99mTc-HMPAO in the reperfused infarct corresponding to low perfusion area].
Sugawara Y; Tanada S; Murase K; Inoue T; Miki H; Okumura A; Hamamoto K; Ueda T; Ohta S; Sakaki S
Kaku Igaku; 1994 Jun; 31(6):603-7. PubMed ID: 8072234
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-d,l-HMPAO and SPECT of the brain in normal aging.
Waldemar G; Hasselbalch SG; Andersen AR; Delecluse F; Petersen P; Johnsen A; Paulson OB
J Cereb Blood Flow Metab; 1991 May; 11(3):508-21. PubMed ID: 2016360
[TBL] [Abstract][Full Text] [Related]
16. Cobalt-57 and technetium-99m-HMPAO-labeled leukocytes for visualization of ischemic infarcts.
Stevens H; Van de Wiele C; Santens P; Jansen HM; De Reuck J; Dierckx R; Korf J
J Nucl Med; 1998 Mar; 39(3):495-8. PubMed ID: 9529298
[TBL] [Abstract][Full Text] [Related]
17. Cerebral infarction within six hours of onset: prediction of completed infarction with technetium-99m-HMPAO SPECT.
Shimosegawa E; Hatazawa J; Inugami A; Fujita H; Ogawa T; Aizawa Y; Kanno I; Okudera T; Uemura K
J Nucl Med; 1994 Jul; 35(7):1097-103. PubMed ID: 8014664
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow.
Andersen AR
Cerebrovasc Brain Metab Rev; 1989; 1(4):288-318. PubMed ID: 2701656
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-ECD SPECT fails to show focal hyperemia of acute herpes encephalitis.
Fazekas F; Roob G; Payer F; Kapeller P; Strasser-Fuchs S; Aigner RM
J Nucl Med; 1998 May; 39(5):790-2. PubMed ID: 9591576
[TBL] [Abstract][Full Text] [Related]
20. Kinetic behavior of technetium-99m-HMPAO in the human brain and quantification of cerebral blood flow using dynamic SPECT.
Murase K; Tanada S; Fujita H; Sakaki S; Hamamoto K
J Nucl Med; 1992 Jan; 33(1):135-43. PubMed ID: 1730979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
